Signal Dx Shifts Focus, Targets Amplification Technology for US Market | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – Having an innovative technology means little if you can't get your products to your target audience. It's a lesson start-up molecular diagnostics firm Signal Diagnostic had to learn, and as a result, it is now recalibrating its business with a focus on the US and new targets for its technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.